The emergence of lncRNAs in cancer biology

JR Prensner, AM Chinnaiyan - Cancer discovery, 2011 - aacrjournals.org
The discovery of numerous noncoding RNA (ncRNA) transcripts in species from yeast to
mammals has dramatically altered our understanding of cell biology, especially the biology …

The microcosmos of cancer

A Lujambio, SW Lowe - Nature, 2012 - nature.com
The discovery of microRNAs (miRNAs) almost two decades ago established a new
paradigm of gene regulation. During the past ten years these tiny non-coding RNAs have …

Targeting EZH2 in cancer therapy

M Yamagishi, K Uchimaru - Current opinion in oncology, 2017 - journals.lww.com
Current Opinion in Oncology Log in or Register Subscribe to journalSubscribe Get new issue
alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation Subscribe …

Epidemiologic, genetic, pathogenic, metabolic, epigenetic aspects involved in NASH-HCC: current therapeutic strategies

J Gutiérrez-Cuevas, S Lucano-Landeros… - Cancers, 2022 - mdpi.com
Simple Summary Hepatocellular carcinoma (HCC) is an aggressive human cancer and is
caused as consequences of chronic liver diseases. Although HCC is more common in …

MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes

C Liu, R Liu, D Zhang, Q Deng, B Liu, HP Chao… - Nature …, 2017 - nature.com
MicroRNAs play important roles in regulating tumour development, progression and
metastasis. Here we show that one of the miR-200 family members, miR-141, is under …

[HTML][HTML] m1A regulated genes modulate PI3K/AKT/mTOR and ErbB pathways in gastrointestinal cancer

Y Zhao, Q Zhao, PJ Kaboli, J Shen, M Li, X Wu… - Translational …, 2019 - Elsevier
BACKGROUND: Gene expression can be posttranscriptionally regulated by a complex
network of proteins. N1-methyladenosine (m1A) is a newly validated RNA modification …

[HTML][HTML] Genomic and epigenomic alterations in cancer

BVSK Chakravarthi, S Nepal, S Varambally - The American journal of …, 2016 - Elsevier
Multiple genetic and epigenetic events characterize tumor progression and define the
identity of the tumors. Advances in high-throughput technologies, like gene expression …

[HTML][HTML] The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc

JR Prensner, W Chen, S Han, MK Iyer, Q Cao… - Neoplasia, 2014 - Elsevier
Long non-coding RNAs (lncRNAs) represent an emerging layer of cancer biology,
contributing to tumor proliferation, invasion, and metastasis. Here, we describe a role for the …

EZH2: biology, disease, and structure-based drug discovery

J Tan, Y Yan, X Wang, Y Jiang, HE Xu - Acta Pharmacologica Sinica, 2014 - nature.com
EZH2 is the catalytic subunit of the polycomb repressive complex 2 (PRC2), which is a
highly conserved histone methyltransferase that methylates lysine 27 of histone 3 …

Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR …

P Dong, Y **ong, Y Konno, K Ihira, N Kobayashi… - Journal of Experimental …, 2021 - Springer
Background Epithelial-to-mesenchymal transition (EMT) and aerobic glycolysis are
fundamental processes implicated in cancer metastasis. Although increasing evidence …